Acumen Pharmaceuticals phase 2 Alzheimer's trial misses primary endpoint

Immunome secures EMA validation of varegacestat application for desmoid tumors

FDA approves Sun Pharma's ILUMYA for psoriatic arthritis

Alkermes initiates phase 2 study of ALKS 7290 for major depressive disorder

Phrontline Biopharma reports preliminary safety and antitumour activity for TJ101

HR HealthCare establishes charitable arm

Sobi presents phase 3 gout study results for pozdeutinurad

TME Pharma signs exclusive negotiation agreement with Japan's TMS for NOX-A12 rights

Formation Bio establishes USD600m debut fund for drug development

Ascletis reports positive US Phase II topline results for ASC30 in diabetes

MetaVia announces presentation of DA-1726 Phase 1 data at Precision Liver Symposium

Genmab reports 50% reduction in risk of death in Phase 3 head and neck cancer trial

United Therapeutics receives FDA clearance to advance inhaled PAH therapy into clinical trials

US WorldMeds acquires Orbus Therapeutics

DifGen Pharmaceuticals completes European Decentralised Procedure for Tafamidis 61 mg Capsules